153 related articles for article (PubMed ID: 7489343)
1. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
[TBL] [Abstract][Full Text] [Related]
2. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
[TBL] [Abstract][Full Text] [Related]
7. Significance of IgM anti-HCV core level in chronic hepatitis C.
Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
[TBL] [Abstract][Full Text] [Related]
8. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
[TBL] [Abstract][Full Text] [Related]
9. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
[TBL] [Abstract][Full Text] [Related]
12. Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.
Ciccorossi P; Filipponi F; Oliveri F; Campani D; Colombatto P; Bonino F; Campa M; Maltinti G; Mosca F; Brunetto MR
J Viral Hepat; 2003 May; 10(3):168-73. PubMed ID: 12753334
[TBL] [Abstract][Full Text] [Related]
13. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
15. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
[TBL] [Abstract][Full Text] [Related]
16. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study.
Flichman D; Colombatto P; Randone A; Baldi M; Bellati G; Negro F; Oliveri F; Colucci G; Verme G; Bonino F; Brunetto MR
Clin Diagn Virol; 1997 May; 8(1):63-70. PubMed ID: 9248659
[TBL] [Abstract][Full Text] [Related]
18. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
19. Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein.
Chen M; Sönnerborg A; Sällberg M
J Clin Microbiol; 1995 Mar; 33(3):778-80. PubMed ID: 7538513
[TBL] [Abstract][Full Text] [Related]
20. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]